Novo Nordisk Has High Hopes for Diabetes Blockbuster - Seeking Alpha (blog)


Novo Nordisk Has High Hopes for Diabetes Blockbuster
Seeking Alpha (blog)
Novo Nordisk (NVO) has secured US Food and Drug Administration approval for Victoza, its type 2 diabetes treatment for adults. The company, which has waited
STOCKS NEWS EUROPE-Novo Nordisk down after Q4 resultsReuters UK
Novo Nordisk increased operating profit by 21% in 2009PharmaLive.com (press release)
Novo Nordisk Profit Little Changed on Higher CostsBusinessWeek
Wall Street Journal -MarketWatch -Pharmacy Europe
all 54 news articles »

Read More About Diabetes

Explore posts in the same categories: Diabetes Mellitus

Comment:

You must be logged in to post a comment.